Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Polymer Composite May Eliminate Bone Formation in Soft Tissue

With support from a 3-year, $2.9 million grant from the U.S. Department of Defense, researchers at Carnegie Mellon University, the U.S. Military Academy and the Naval Medical Center are developing nanostructural polymer-based treatments that may eliminate the pathological formation of bone in soft tissue that commonly follows orthopaedic surgeries and limb amputations.

Data indicates that heterotopic ossification occurs in >60% of military personnel who incur bone injury resulting in amputation. Further, >90% of hip replacement procedures in the civilian U.S. population show signs of ossification.

The research team is focusing upon a nanostructural polymer composite to deliver a ribonucleic acid directly to cells at the trauma site. CMU researchers report there is a patent pending on the therapy and a clinical trial schedule will be developed once the preventative platform is fully lab-tested.


CMU Research Team Develops Tools to Ease the Pain of Combat Injuries, August 31, 2012,
Bone Tissue Engineering Center Gets Grant to Help Soldiers, June 2012,